Mercury Laboratories Limited

BSE: 538964
Mercury Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L74239MH1982PLC026341 Incorporated 12 February 1982 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 538964 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹75.94 Cr
▲ 1.11% YoY
EBITDA · FY 2026
₹11 Cr
▲ 36.01% YoY
Net profit · FY 2026
₹4.83 Cr
▲ 53.71% YoY
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹1.2 Cr
Issued & subscribed
Open charges
₹17.71 Cr
Satisfied ₹33.61 Cr
Company age
44 yrs
Est. 1982
Employees · EPFO
471
Latest available

About Mercury Laboratories Limited

Data last updated: 04 January 2026

Mercury Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 12 February 1982, the company has been in operation for over 44 years.

Registered with ROC Mumbai under CIN L74239MH1982PLC026341. Listed on BSE: 538964.

Capital: an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.2 Cr. Formerly known as Mercury Laboratories Private Limited. It is led by directors including Janki Rajendra Shah and Sanjay Shantilal Patel.

Last AGM: 13 August 2025. Financial statements filed for year ended 31 March 2025. Office: Shreeji Mang Idas Marketprincess Street, Mumbai, Maharashtra, India – 400002.

As per the financials filed for FY 2025, the company reported a revenue of ₹76.17 Cr, a decline of 1% compared to the previous year.

The company has a workforce of approximately 471 employees as per the latest available data.

The company is associated with 1 brand - Mercury Laboratories. As per MCA filings, the company has open charges of ₹17.71 Cr and satisfied charges of ₹33.61 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mercurylabs.com.

Company Details of Mercury Laboratories Limited
CIN L74239MH1982PLC026341
Registration Number 026341
Incorporation Date 12 February 1982
ROC Mumbai
Listing Status Listed (BSE: 538964)
Company Status Active
Date of Last AGM 13 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Rajendrakumar Ramanlal Shah Managing Director Janki Rajendra Shah Director Sanjay Shantilal Patel Additional Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    mercurylabs.com
  • Social Media
  • Registered Address
    Shreeji Mang Idas Marketprincess Street, Mumbai, Maharashtra, India – 400002
  • Industry
    Pharma, Drug Formulation & Development
Company report
Mercury Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Mercury Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Mercury Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Mercury Laboratories Limited

Mercury Laboratories Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74239MH1982PLC026341, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74239MH1982PLC026341 Current
U74239MH1982PTC026341 Previous
U74239MH1982PLC026341 Previous

Associated Brands with Mercury Laboratories Limited

Mercury Laboratories Limited operates one associated brand: Mercury Laboratories. These brands represent Mercury Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Mercury Laboratories
Pharmaceutical drugs are manufactured by Mercury Laboratories in India. mercurylabs.com

Business Activity of Mercury Laboratories Limited

Mercury Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Mercury Laboratories Limited

Mercury Laboratories Limited is audited by M/s NARESH AND CO (ICAI peer reviewed, certificate valid till 2027-10-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s NARESH AND CO (ICAI peer reviewed, certificate valid till 2027-10-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Mercury Laboratories Limited

Mercury Laboratories Limited is currently managed by 8 directors, with 17 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Janki Rajendra Shah
Also directs: Mercury Laboratories Limited, Mercury Antibiotics Llp
Director 05 Feb 2020 6 Years 5 Months Current
Sanjay Shantilal Patel
Also directs: Mercury Laboratories Limited, Ace Blue Ventures Llp, Aromix Private Limited and 4 more
Additional Director 14 May 2025 1 Years 1 Months Current
Jayantilal Dhaneshwar Raval
Also directs: Mercury Laboratories Limited
Director 24 Jul 2024 1 Years 11 Months Current
Paresh Jagdishbhai Mistry
Also directs: Mercury Laboratories Limited
Director 01 Oct 2017 8 Years 9 Months Current
Dilip Ramanlal Shah
Also directs: Mercury Laboratories Limited
Director 16 Feb 1982 44 Years 4 Months Current
Rajendrakumar Ramanlal Shah
Also directs: Mercury Laboratories Limited
Managing Director 16 Feb 1982 44 Years 4 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Mercury Laboratories Limited FY 2026 filings available

Mercury Laboratories Limited reported revenue of ₹75.94 Cr (up 1.11% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹75.94 Cr ▲ 1.11%
Profit · FY 2026
₹4.83 Cr ▲ 53.71%
EBITDA · FY 2026
₹11 Cr ▲ 36.01%
Revenue₹ Cr · Standalone050100FY 2019: ₹56 Cr55.5FY 2019FY 2020: ₹57 Cr · +3.1% YoY57.3+3.1%FY 2020FY 2021: ₹69 Cr · +19.8% YoY68.6+19.8%FY 2021FY 2022: ₹58 Cr · -15.6% YoY57.9-15.6%FY 2022FY 2023: ₹75 Cr · +30.1% YoY75.3+30.1%FY 2023FY 2024: ₹76 Cr · +0.3% YoY75.6+0.3%FY 2024FY 2025: ₹75 Cr · -0.6% YoY75.1-0.6%FY 2025FY 2026: ₹76 Cr · +1.1% YoY75.9+1.1%FY 2026
Net Profit₹ Cr · Standalone0246FY 2019: ₹3 Cr2.8FY 2019FY 2020: ₹3 Cr · +13.8% YoY3.2+13.8%FY 2020FY 2021: ₹5 Cr · +65.3% YoY5.3+65.3%FY 2021FY 2022: ₹4 Cr · -30.9% YoY3.7-30.9%FY 2022FY 2023: ₹6 Cr · +51.3% YoY5.6+51.3%FY 2023FY 2024: ₹6 Cr · +1.4% YoY5.7+1.4%FY 2024FY 2025: ₹3 Cr · -44.4% YoY3.1-44.4%FY 2025FY 2026: ₹5 Cr · +53.7% YoY4.8+53.7%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0102030Q1'25: ₹17 Cr16.7Q1'25Q2'25: ₹18 Cr18.2Q2'25Q3'25: ₹20 Cr19.6Q3'25Q4'25: ₹21 Cr20.7Q4'25Q1'26: ₹18 Cr · +8.7% YoY18.1+8.7%Q1'26Q2'26: ₹19 Cr · +4.5% YoY19+4.5%Q2'26Q3'26: ₹18 Cr · -6.2% YoY18.4-6.2%Q3'26Q4'26: ₹20 Cr · -1% YoY20.4-1%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹75.94 Cr ₹75.1 Cr ₹75.56 Cr ₹75.33 Cr ₹57.92 Cr ₹68.6 Cr ₹57.27 Cr ₹55.52 Cr
Other Income ₹1.96 Cr ₹1.07 Cr ₹1.09 Cr ₹1.72 Cr ₹81.59 Lakh ₹88.02 Lakh ₹84.95 Lakh ₹1.04 Cr
Total Income ₹77.89 Cr ₹76.17 Cr ₹76.65 Cr ₹77.05 Cr ₹58.74 Cr ₹69.48 Cr ₹58.12 Cr ₹56.56 Cr
Cost of Materials Consumed ₹25.36 Cr ₹27.45 Cr ₹28.09 Cr ₹28.57 Cr ₹21.83 Cr ₹29.48 Cr ₹23.07 Cr ₹23.33 Cr
Purchases of Stock-in-Trade ₹2.28 Cr ₹2.21 Cr ₹2.36 Cr ₹2.39 Cr ₹2.05 Cr ₹1.53 Cr ₹1.73 Cr ₹1.26 Cr
Changes in Inventories ₹1.89 Cr -₹74.27 Lakh -₹14.76 Lakh -₹54.52 Lakh -₹22 Lakh ₹15.88 Lakh ₹84.22 Lakh ₹1.75 Cr
Employee Benefit Expense ₹17.44 Cr ₹16.84 Cr ₹14.5 Cr ₹14.23 Cr ₹12.37 Cr ₹9.8 Cr ₹9.3 Cr ₹7.83 Cr
Finance Costs ₹54.48 Lakh ₹54.77 Lakh ₹38.3 Lakh ₹36.19 Lakh ₹44.64 Lakh ₹64.14 Lakh ₹81.75 Lakh ₹1.09 Cr
Depreciation & Amortisation ₹3.42 Cr ₹2.88 Cr ₹2.82 Cr ₹2.48 Cr ₹2.45 Cr ₹1.92 Cr ₹1.87 Cr ₹1.63 Cr
Other Expenses ₹19.94 Cr ₹22.33 Cr ₹21.72 Cr ₹22.12 Cr ₹14.78 Cr ₹18.04 Cr ₹16.16 Cr ₹15.63 Cr
Total Expenses ₹70.86 Cr ₹71.51 Cr ₹69.73 Cr ₹69.61 Cr ₹53.71 Cr ₹61.57 Cr ₹53.79 Cr ₹52.51 Cr
Profit Before Exceptional Items & Tax ₹7.03 Cr ₹4.66 Cr ₹6.92 Cr ₹7.44 Cr ₹5.03 Cr ₹7.91 Cr ₹4.33 Cr ₹4.05 Cr
Exceptional Items -₹39.49 Lakh ₹0 ₹0 ₹4.83 Lakh ₹12.75 Lakh ₹0 ₹0 ₹0
Profit Before Tax ₹6.64 Cr ₹4.66 Cr ₹6.92 Cr ₹7.49 Cr ₹5.16 Cr ₹7.91 Cr ₹4.33 Cr ₹4.05 Cr
Total Tax Expense ₹1.8 Cr ₹1.52 Cr ₹1.27 Cr ₹1.91 Cr ₹1.47 Cr ₹2.57 Cr ₹1.1 Cr ₹1.21 Cr
Net Profit ₹4.83 Cr ₹3.14 Cr ₹5.65 Cr ₹5.58 Cr ₹3.69 Cr ₹5.34 Cr ₹3.23 Cr ₹2.84 Cr
Other Comprehensive Income ₹9.33 Lakh ₹58,000 -₹2.45 Lakh ₹16.33 Lakh ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹4.93 Cr ₹3.15 Cr ₹5.63 Cr ₹5.74 Cr ₹3.69 Cr ₹5.34 Cr ₹3.23 Cr ₹2.84 Cr
EBITDA (computed) ₹11 Cr ₹8.09 Cr ₹10.12 Cr ₹10.29 Cr ₹7.93 Cr ₹10.47 Cr ₹7.02 Cr ₹6.77 Cr
Basic EPS ₹40.28 ₹26.21 ₹47.12 ₹46.49 ₹30.72 ₹44.48 ₹26.90 ₹23.64
Diluted EPS ₹40.28 ₹26.21 ₹47.12 ₹46.49 ₹30.72 ₹44.48 ₹26.90 ₹23.64
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹79.08 Cr ₹74.24 Cr ₹67.96 Cr ₹67.58 Cr ₹63.22 Cr ₹65.37 Cr ₹56.3 Cr ₹57.3 Cr
Non-current Assets ₹34.14 Cr ₹34.16 Cr ₹28.12 Cr ₹25.87 Cr ₹27.21 Cr ₹27.57 Cr ₹24.79 Cr ₹25.4 Cr
Current Assets ₹44.95 Cr ₹40.08 Cr ₹39.84 Cr ₹41.71 Cr ₹36.01 Cr ₹37.8 Cr ₹31.51 Cr ₹31.9 Cr
Property, Plant & Equipment ₹23.88 Cr ₹24.62 Cr ₹24.01 Cr ₹24.22 Cr ₹25.76 Cr ₹26.27 Cr ₹23.62 Cr ₹24.31 Cr
Inventories ₹7.12 Cr ₹7.21 Cr ₹6.21 Cr ₹6.9 Cr ₹6.78 Cr ₹5.16 Cr ₹5.51 Cr ₹6.78 Cr
Trade Receivables ₹25.85 Cr ₹25.74 Cr ₹21.85 Cr ₹21.37 Cr ₹17.54 Cr ₹22.54 Cr ₹18.14 Cr ₹19.29 Cr
Cash & Equivalents ₹80.32 Lakh ₹33.18 Lakh ₹3.29 Cr ₹3.71 Cr ₹4.11 Cr ₹3.03 Cr ₹1.3 Cr ₹28.58 Lakh
Equity (Net Worth) ₹58.08 Cr ₹53.57 Cr ₹50.84 Cr ₹45.63 Cr ₹40.34 Cr ₹36.89 Cr ₹31.98 Cr ₹28.97 Cr
Equity Share Capital ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr ₹1.2 Cr
Borrowings (Non-current) ₹6.74 Cr ₹3.04 Cr ₹2.86 Cr ₹2.42 Cr ₹5.07 Cr ₹6.24 Cr ₹6.33 Cr ₹8.5 Cr
Borrowings (Current) ₹66.87 Lakh ₹1.05 Cr ₹2.63 Cr ₹2.94 Cr ₹0 ₹0 ₹0 ₹0
Total Debt (computed) ₹7.41 Cr ₹4.09 Cr ₹5.5 Cr ₹5.36 Cr ₹5.07 Cr ₹6.24 Cr ₹6.33 Cr ₹8.5 Cr
Current Liabilities ₹11.69 Cr ₹15.08 Cr ₹12.94 Cr ₹16.43 Cr ₹13.63 Cr ₹18.83 Cr ₹15.07 Cr ₹16.92 Cr
Total Liabilities ₹21.01 Cr ₹20.67 Cr ₹17.12 Cr ₹21.95 Cr ₹22.88 Cr ₹28.48 Cr ₹24.32 Cr ₹28.33 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹4.24 Cr ₹4 Cr ₹8.23 Cr ₹2.45 Cr ₹5.16 Cr
Investing Cash Flow -₹3.17 Cr -₹9.04 Cr -₹6.27 Cr -₹1.06 Cr -
Financing Cash Flow ₹2.91 Cr -₹99.45 Lakh -₹1.04 Cr -₹1.01 Cr -
Capital Expenditure ₹3.17 Cr ₹9.04 Cr ₹6.27 Cr ₹1.06 Cr -
Free Cash Flow (computed) ₹1.07 Cr -₹5.04 Cr ₹1.95 Cr ₹1.4 Cr -
Dividends Paid ₹42 Lakh ₹42 Lakh ₹42 Lakh ₹42 Lakh -
Net Change in Cash ₹3.99 Cr -₹6.03 Cr ₹91.14 Lakh ₹38.28 Lakh ₹5.16 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹20.44 Cr ₹18.35 Cr ₹19.01 Cr ₹18.14 Cr ₹20.66 Cr ₹19.57 Cr ₹18.19 Cr ₹16.68 Cr
Other Income ₹67.09 Lakh ₹31.24 Lakh ₹79.08 Lakh ₹18.1 Lakh ₹18.45 Lakh ₹52.9 Lakh ₹20.55 Lakh ₹14.98 Lakh
Total Income ₹21.11 Cr ₹18.66 Cr ₹19.8 Cr ₹18.32 Cr ₹20.84 Cr ₹20.1 Cr ₹18.4 Cr ₹16.83 Cr
Cost of Materials Consumed ₹6.9 Cr ₹6.3 Cr ₹6.22 Cr ₹5.94 Cr ₹8.15 Cr ₹7.12 Cr ₹7.54 Cr ₹4.65 Cr
Purchases of Stock-in-Trade ₹75.24 Lakh ₹57.67 Lakh ₹60.92 Lakh ₹33.78 Lakh ₹69.32 Lakh ₹63.31 Lakh ₹36.33 Lakh ₹51.59 Lakh
Changes in Inventories ₹19.29 Lakh ₹16.46 Lakh ₹56 Lakh ₹97.4 Lakh -₹79.12 Lakh -₹19.33 Lakh -₹1.09 Cr ₹1.33 Cr
Employee Benefit Expense ₹4.57 Cr ₹4.17 Cr ₹4.45 Cr ₹4.24 Cr ₹4.36 Cr ₹4.31 Cr ₹4.33 Cr ₹3.84 Cr
Finance Costs ₹13.05 Lakh ₹13.75 Lakh ₹13.21 Lakh ₹14.53 Lakh ₹13.12 Lakh ₹12.71 Lakh ₹15.13 Lakh ₹13.81 Lakh
Depreciation & Amortisation ₹84.39 Lakh ₹86.91 Lakh ₹86.32 Lakh ₹84.34 Lakh ₹72.95 Lakh ₹73.51 Lakh ₹71.28 Lakh ₹69.84 Lakh
Other Expenses ₹5.98 Cr ₹4.62 Cr ₹5.05 Cr ₹4.29 Cr ₹6.12 Cr ₹5.73 Cr ₹5.75 Cr ₹4.73 Cr
Total Expenses ₹19.38 Cr ₹16.84 Cr ₹17.88 Cr ₹16.77 Cr ₹19.4 Cr ₹18.46 Cr ₹17.75 Cr ₹15.91 Cr
Profit Before Exceptional Items & Tax ₹1.74 Cr ₹1.82 Cr ₹1.92 Cr ₹1.55 Cr ₹1.45 Cr ₹1.64 Cr ₹65.27 Lakh ₹91.93 Lakh
Exceptional Items ₹0 -₹39.49 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹1.74 Cr ₹1.43 Cr ₹1.92 Cr ₹1.55 Cr ₹1.45 Cr ₹1.64 Cr ₹65.27 Lakh ₹91.93 Lakh
Total Tax Expense ₹51.14 Lakh ₹43.23 Lakh ₹27.98 Lakh ₹57.97 Lakh ₹33.65 Lakh ₹45.02 Lakh ₹15.23 Lakh ₹57.78 Lakh
Net Profit ₹1.23 Cr ₹99.75 Lakh ₹1.64 Cr ₹96.76 Lakh ₹1.11 Cr ₹1.19 Cr ₹50.04 Lakh ₹34.15 Lakh
Other Comprehensive Income ₹7.47 Lakh ₹2.03 Lakh -₹33,000 ₹15,000 -₹1.72 Lakh ₹77,000 ₹92,000 ₹61,000
Total Comprehensive Income ₹1.3 Cr ₹1.02 Cr ₹1.64 Cr ₹96.91 Lakh ₹1.09 Cr ₹1.2 Cr ₹50.96 Lakh ₹34.76 Lakh
EBITDA (computed) ₹2.71 Cr ₹2.83 Cr ₹2.92 Cr ₹2.54 Cr ₹2.31 Cr ₹2.51 Cr ₹1.52 Cr ₹1.76 Cr
Basic EPS ₹10.21 ₹8.31 ₹13.69 ₹8.06 ₹9.25 ₹9.94 ₹4.17 ₹2.85
Diluted EPS ₹10.21 ₹8.31 ₹13.69 ₹8.06 ₹9.25 ₹9.94 ₹4.17 ₹2.85
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Mercury Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Mercury Laboratories Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 73.66%, retail and other public shareholders hold 26.34% of Mercury Laboratories Limited. The company had 1,316 shareholders on record.

Promoters: 73.66%Retail & Others: 26.34%
Mar 2026
QUARTER
73.66% Promoters
26.34% Retail & Others
Promoter holding - history
Now 73.66% · Mar 2026High 73.66% · Jun 2023Low 73.66% · Jun 2023
72%72.8%73.5%74.3%75%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 73.66%Sep 2023: 73.66%Dec 2023: 73.66%Mar 2024: 73.66%Jun 2024: 73.66%Sep 2024: 73.66%Dec 2024: 73.66%Mar 2025: 73.66%Jun 2025: 73.66%Sep 2025: 73.66%Dec 2025: 73.66%Mar 2026: 73.66%73.66%73.66%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters73.66%73.66%73.66%73.66%73.66%73.66%
Public26.34%26.34%26.34%26.34%26.34%26.34%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters73.66%73.66%73.66%
Public26.34%26.34%26.34%
Promoter change (YoY, %pts)+0.00+0.00-

Charges & Borrowings of Mercury Laboratories Limited

Open charges
₹17.71 Cr
Satisfied charges
₹33.61 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹15.81 Cr
Sidbi₹1.90 Cr
Latest charge details
DateLenderAmountStatus
19 Dec 2024 Sidbi ₹1.9 Cr Open
14 Mar 2024 Hdfc Bank Limited ₹20 Lakh Open
25 May 2023 Hdfc Bank Limited ₹50 Lakh Open
27 Sep 2021 Hdfc Bank Limited ₹7.06 Cr Open
21 Jul 2020 Hdfc Bank Limited ₹8.05 Cr Open

Total charge records: 18 View all charges

Employees and EPFO Compliance at Mercury Laboratories Limited

Mercury Laboratories Limited has a workforce of 471 employees as of Oct 10, 2025.

Employee count
471
Active EPFO establishments
1
Employee growth
-3.09%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Mercury Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Mercury Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Mercury Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Mercury Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Mercury Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Mercury Laboratories Limited

MSME Payment Delays by Mercury Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Mercury Laboratories Limited

Subsidiaries & Group Companies of Mercury Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Mercury Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Mercury Laboratories Limited

MCA Filings & Documents of Mercury Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Mercury Laboratories Limited

Activity
13 Aug 2025
Mercury Laboratories Limited last Annual general meeting of members was held on 13 Aug 2025 as per latest MCA records.
Directors
14 May 2025
Sanjay Shantilal Patel was appointed as a Additional Director on 14 May 2025 & has been associated with this company since 1 year 1 month.
Activity
31 Mar 2025
Mercury Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
19 Dec 2024
A charge with Sidbi amounted to Rs. 1.90 Cr with Charge ID 101022958 was registered on 19 Dec 2024.
Directors
24 Jul 2024
Jayantilal Dhaneshwar Raval was appointed as a Director on 24 Jul 2024 & has been associated with this company since 1 year 11 months.
Charges
14 Mar 2024
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100886860 was registered on 14 Mar 2024.

Frequently Asked Questions about Mercury Laboratories Limited

Mercury Laboratories Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 12 February 1982 (44+ years old) and is registered under CIN L74239MH1982PLC026341. Listed on BSE: 538964. The company has 471 employees.

Mercury Laboratories Limited reported revenue of ₹76.17 Cr for FY 2025 (down 1.00% YoY).

The current directors of Mercury Laboratories Limited are:

The primary industry of Mercury Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Mercury Laboratories Limited is listed on BSE with code 538964.

Mercury Laboratories Limited can be reached at the registered office: Shreeji Mang Idas Marketprincess Street, Mumbai, Maharashtra, India – 400002, or through the website mercurylabs.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available